REmote MOnitoring Transmission Evaluation of IPGs
REMOTE-IPG
1 other identifier
interventional
120
1 country
3
Brief Summary
The purpose of this study is to evaluate the potential clinical and economic benefits of using CareLink remote management for pacemaker follow-up. Study Objectives include:
- 1.To determine clinician perceived quality of care for CareLink remote follow-up.
- 2.To determine patient satisfaction with CareLink follow-up.
- 3.To estimate the time required to perform patient follow-up via CareLink remote transmissions.
- 4.To determine the percentage of regular CareLink follow-ups that do not require further in-clinic review of the patient.
- 5.To estimate potential patient cost avoidance for one year of follow up incorporating CareLink.
- 6.To evaluate compliance to scheduled CareLink transmissions with the remote management system
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Mar 2008
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 3, 2008
CompletedFirst Posted
Study publicly available on registry
March 10, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedApril 26, 2018
April 1, 2018
1.7 years
March 3, 2008
April 24, 2018
Conditions
Study Arms (1)
1
EXPERIMENTALPacemaker Patients
Interventions
Substitution of CareLink Remote Monitoring of Pacemakers for in-clinic pacemaker follow-up visits
Eligibility Criteria
You may qualify if:
- Patients who have received a market released Medtronic pacemaker with automatic threshold management features for all active leads.
- Patients who have been implanted with their current pacemaker for at least 3 months.
- Patients who are willing, or who have caregivers willing, to use the Medtronic CareLink Monitor.
- Patients who are willing and able to sign an IRB/MEC approved patient informed consent.
You may not qualify if:
- Patients participating in another study that would affect the objectives of this study
- Patients who have already previously used a Medtronic CareLink Monitor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Kelowna General Hospital
Kelowna, British Columbia, Canada
Southlake Regional Hospital
Newmarket, Ontario, Canada
CHUQ, L'Hotel Dieu de Quebec
Québec, Quebec, Canada
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2008
First Posted
March 10, 2008
Study Start
March 1, 2008
Primary Completion
November 1, 2009
Study Completion
February 1, 2010
Last Updated
April 26, 2018
Record last verified: 2018-04